Patrick Keenan | Managing Director
Prevail Partners

Patrick Keenan, Managing Director, Prevail Partners

Patrick Keenan is the Managing Director of Prevail Partners, LLC, a life sciences investment firm focused on innovative clinical stage therapeutic, medical device and diagnostics companies.  During his nine-year tenure, Prevail Partners has invested in over 30 private and public companies.  These portfolio companies have entered into licensing deals with over $2 billion in payments and completed several successful IPOs.  Patrick was previously in private law practice with a focus on intellectual property and was recognized as among Pennsylvania Super Lawyers™.  He has been a speaker at several healthcare conferences, including Stem Cell Summit 2016, Bio Korea 2013, and others.  Patrick is a board member of Shimojani Inc. and the non-profit Peace of Mind Project.  He obtained his undergraduate degree from Stockton University and Juris Doctorate from Rutgers School of Law.


Precision 2018 Day 1 @ 14:30

Panel: Funding precision medicine – how to fund your projects

  • What are investors most likely to find compelling in an elevator pitch?
  • Is it the science or the team that attracts capital?
  • How can I obtain access to funding sources?
  • What are the benefits and drawbacks of each capital source?

back to speakers

Sign Up for Event Updates

World Precision Medicine Congress


Erica Baeta
+44 (0)207 092 1152


Joan Shutt
t/ +44 (0)207 092 1134


Issa Mauthoor
+44 (0)207 092 1257